RX-DX Deals in Coagulation Monitoring
Executive Summary
In the past, diagnostic companies may have been eager to tap the vast resources of pharmaceutical companies, but the feeling wasn't mutual. The few diagnostics companies that did get involved in such relationships tended to walk away dissatisfied with the attention being paid to them by pharmaceutical partners preoccupied with higher margin opportunities.